Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Co-trimoxazole may help treat autoimmune diseases.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Blocking interferon-gamma might help treat various autoimmune diseases.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.